LLY Directional Report
Analysis based on market close March 31, 2026
Outlook
Neutral with a slight bullish bias, anchored by spot at max pain ($920). Confidence: 5/10. The market is pinned near-term but shows conflicting internal signals: strong bullish flow is offset by negative GEX, suggesting underlying volatility and a lack of dealer support for a sustained rally.
Conflicts: GEX -$2.7M (trending/volatile regime), P/C OI ratio 1.35 (structural put skew), falling max pain trend.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-2.7M
DEX: +7.0M shares
Gamma flip: ~$400 (Approx โ based on put OI concentration of 3,177)
NTM gamma: Gamma flip ~$400 is far below spot, indicating minimal near-the-money gamma. Dealer hedging is sparse near spot, so moves will be less dampened. A move ยฑ2% will not trigger significant new dealer flows near-term.
IV Analysis
IV vs VIX: IV 48.4% is elevated โ premium selling is attractive, but negative GEX increases risk of large moves.
Term structure: **Steep front-month decay**: 4/2 IV 52.2% โ 4/10 IV 45.3% (~7 vol-pt drop). Hump at 5/1 (49.7%) likely pricing April earnings.
Skew: **Front-week calendar spread edge**: Sell high IV (52.2%) in 4/2, buy lower IV (45.3%) in 4/10.
Flow Analysis
Net premium: +$71.2M bullish; P/C vol 0.37 (extreme call volume), P/C OI 1.35 (structural put OI).
Directional prints: $1000C 4/10 vol 1,975 vs OI 183 (10.8x) โ likely **bought calls** as bullish bet or hedge. $1050C 4/10 vol 4,180 vs OI 227 (18.4x) โ similar bullish/hedging activity. Interpretation favors bought calls given net premium direction.
Unusual: $1100C 4/2 vol 1,305 at IV 75.0% โ extremely rich vol for a weekly OTM call; could be a volatility sale or a low-probability lottery ticket.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Moderate-Weak | Buy shares at $920. | Negative GEX and falling max pain trend provide headwinds; better to sell premium against shares. |
| Short stock | Moderate | Short shares at $920. | Strong bullish flow and spot at max pain create near-term pin risk; consider pairing with a call. |
| Covered call | Moderate-Strong | Own stock, sell $960C or $1000C (4/17 or later). | Stock drifts lower (max pain trend); call premium offsets some loss. |
| Cash-secured put / put spread | Moderate | Sell $890P (4/10) or $890/$870 put spread (4/17). | Negative GEX increases odds of hitting strike; defined-risk spread preferred. |
| Long calls | Moderate-Weak | Buy $940C or $960C (4/17). | High IV (41.7%) and negative GEX make directional calls expensive; needs a strong bullish catalyst. |
| Long puts / bear put spread | Moderate-Strong | Buy $900/$880 put spread (4/17). | Aligns with negative GEX and falling max pain trend; defined risk. |
| Iron condor | Weak | e.g., $890/$870P x $960/$980C (4/17). | GEX negative AND IV > 28 โ mechanically weak rating. Negative GEX regime favors directional plays, not range-bound. |
| Calendar/diagonal | Moderate-Strong | **Reverse Calendar**: Sell $920C (4/2, IV 52.2%), Buy $920C (4/10, IV 45.3%). | Pin breaks and spot moves sharply; best if spot stays near $920. |
| PMCC / LEAPS diagonal | Moderate | Buy $850C (1/15/27, IV 41.0%), Sell $960C (4/17, IV 41.7%). | Long-dated bullish thesis challenged by near-term bearish drift; capital intensive. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for LLY. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.